Drug Testing Locations - Preston, CT

Drug Testing in Preston, CT

Preston, Connecticut Statistics

In Preston, CT, New London County, 15% of residents reported illicit drug use at least once in the past year.

Preston, located in New London County, saw a 23% increase in opioid overdose cases from the previous year.

New London County, including Preston, has a substance use disorder treatment needs rate of nearly 9%.

In New London County, where Preston is situated, opioid prescriptions have decreased by 20% over the past five years.

About 12% of high school students in Preston, CT, New London County, admitted to using marijuana.

Preston, CT, in New London County, experienced a 17% increase in drug-related arrests last year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Preston, CT & Drug Testing Policies

Employers in Preston, CT, are implementing strict drug testing policies to ensure workplace safety and compliance with state regulations. Many businesses adhere to guidelines from the U.S. Department of Labor to create drug-free environments, offering employee assistance programs to support those seeking help.

Random and pre-employment drug testing are becoming more common in Preston, monitored to protect privacy while deterring substance abuse. Employers also educate their workforce about the risks of drug use and underline the availability of resources and support for affected employees.

Government Efforts with Drug Problems in Preston, CT

In Preston, CT, the government has initiated several programs to tackle the drug abuse problem, including partnerships with local health organizations and law enforcement agencies. The state government has provided resources for addiction treatment through various Connecticut Department of Mental Health and Addiction Services programs and grants.

Additionally, the Connecticut Department of Public Health collaborates with local agencies in New London County to conduct awareness campaigns and distribute Naloxone, reversing opioid overdoses, to first responders and citizens alike.

Local Drug Busts & News in Preston, CT

Preston, CT, has witnessed several significant drug-related events, including notable busts that highlight the growing drug issue within New London County. Recently, a substantial bust led by local law enforcement seized multiple kilograms of heroin destined for distribution across various towns, including Preston.

Community outreach events are often held to combat drug issues by promoting awareness and engaging residents directly. Law enforcement agencies frequently share information in public forums about their ongoing efforts to eradicate drug trafficking and provide citizens with insights into keeping their community safe.

In another incident, law enforcement agencies intercepted a synthetic drug that had been circulating among young adults, emphasizing the need for proactive community and school programs to prevent early substance use and addiction.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Preston, CT. Trusted by employers nationwide for accurate results and exceptional service.

Connecticut DOT/Non DOT Physicals

Connecticut Vision Tests

Connecticut Audiograms

Connecticut Respirator Fit Tests

Connecticut Lift Tests

Connecticut Background Checks

Clinical Testing Services

TB Testing in CT

Diabetes Testing in CT

Infectious Disease Testing in CT

Sickle Cell Anemia Testing in CT

Women/Men's Health Testing in CT

Resources & Citations

Department of Mental Health and Addiction Services

Department of Public Health

SBIRT Connecticut

CT Addiction Services

Sound Community Services

Alliance for Living

City of Norwich Human Services

United Community and Family Services

Waterford Country School's Mental Health Clinic

Drug Testing Near Preston, CT

Bozrah, CT

Baltic, CT

Sprague, CT

Griswold, CT

Jewett City, CT

Montville, CT

Gales Ferry, CT

Oxoboxo River, CT

Uncasville, CT

Lisbon, CT

Mashantucket, CT

New Preston, CT

Norwich, CT

Frequently Asked Questions

Customer Reviews